# Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management

> clinical trial · VERIFIED · 2026-08-24

Status: ACTIVE_NOT_RECRUITING · Sponsor: Memorial Sloan Kettering Cancer Center · Condition: Rectal Cancer

- Company: Memorial Sloan Kettering Cancer Center
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT02008656

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.